自评健康状况是预测血液或骨髓移植术后晚期死亡率的独立指标:血液或骨髓移植幸存者研究报告》。

IF 6.1 2区 医学 Q1 ONCOLOGY
Cancer Pub Date : 2024-10-08 DOI:10.1002/cncr.35598
Nora Balas PhD, Joshua Richman MD, PhD, Wendy Landier PhD, RN, Sadeep Shrestha PhD, Katia J. Bruxvoort PhD, MPH, Lindsey Hageman MPH, Qingrui Meng MS, Elizabeth Ross MBA, Alysia Bosworth BA, Hok Sreng Te BA, F. Lennie Wong PhD, Ravi Bhatia MD, Stephen J. Forman MD, Saro H. Armenian DO, MPH, Daniel J. Weisdorf MD, Smita Bhatia MD, MPH
{"title":"自评健康状况是预测血液或骨髓移植术后晚期死亡率的独立指标:血液或骨髓移植幸存者研究报告》。","authors":"Nora Balas PhD,&nbsp;Joshua Richman MD, PhD,&nbsp;Wendy Landier PhD, RN,&nbsp;Sadeep Shrestha PhD,&nbsp;Katia J. Bruxvoort PhD, MPH,&nbsp;Lindsey Hageman MPH,&nbsp;Qingrui Meng MS,&nbsp;Elizabeth Ross MBA,&nbsp;Alysia Bosworth BA,&nbsp;Hok Sreng Te BA,&nbsp;F. Lennie Wong PhD,&nbsp;Ravi Bhatia MD,&nbsp;Stephen J. Forman MD,&nbsp;Saro H. Armenian DO, MPH,&nbsp;Daniel J. Weisdorf MD,&nbsp;Smita Bhatia MD, MPH","doi":"10.1002/cncr.35598","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The prevalence of suboptimal self-rated health (SRH) and its association with subsequent all-cause and cause-specific mortality after blood or marrow transplantation (BMT) were examined.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Study participants were drawn from the multicenter Blood or Marrow Transplant Survivor Study, and included patients who were transplanted between 1974 and 2014 and had survived ≥2 years after BMT. Participants (aged ≥18 years) completed a survey at a median of 9 years from BMT, and were followed for a median of 5.6 years after survey completion. Survivors provided information on sociodemographic factors, chronic health conditions, health behaviors, and SRH (a single-item measure rated as excellent, very good, good, fair, or poor; excellent, very good, and good SRH were classified as good SRH, and fair and poor were classified as suboptimal SRH). The National Death Index Plus and Accurint databases and medical records provided vital status through December 2021.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 3739 participants, 784 died after survey completion (21%). Overall, 879 BMT survivors (23.5%) reported suboptimal SRH. Pain, low socioeconomic status, psychological distress, lack of exercise, severe/life-threatening chronic health conditions, post-BMT relapse, obesity, smoking, and male sex were associated with suboptimal SRH. BMT survivors who reported suboptimal SRH had a 1.9-fold increased risk of all-cause mortality (95% confidence interval [CI], 1.6–2.3), 1.8-fold increased risk of recurrence-related mortality (95% CI, 1.4–2.5), and 1.9-fold increased risk of non–recurrence-related mortality (95% CI, 1.4–2.4) compared to those who reported good SRH.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This single-item measure could help identify vulnerable subpopulations who could benefit from interventions to mitigate the risk for subsequent mortality.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Self-rated health is an independent predictor of subsequent late mortality after blood or marrow transplantation: A Blood or Marrow Transplant Survivor Study report\",\"authors\":\"Nora Balas PhD,&nbsp;Joshua Richman MD, PhD,&nbsp;Wendy Landier PhD, RN,&nbsp;Sadeep Shrestha PhD,&nbsp;Katia J. Bruxvoort PhD, MPH,&nbsp;Lindsey Hageman MPH,&nbsp;Qingrui Meng MS,&nbsp;Elizabeth Ross MBA,&nbsp;Alysia Bosworth BA,&nbsp;Hok Sreng Te BA,&nbsp;F. Lennie Wong PhD,&nbsp;Ravi Bhatia MD,&nbsp;Stephen J. Forman MD,&nbsp;Saro H. Armenian DO, MPH,&nbsp;Daniel J. Weisdorf MD,&nbsp;Smita Bhatia MD, MPH\",\"doi\":\"10.1002/cncr.35598\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The prevalence of suboptimal self-rated health (SRH) and its association with subsequent all-cause and cause-specific mortality after blood or marrow transplantation (BMT) were examined.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Study participants were drawn from the multicenter Blood or Marrow Transplant Survivor Study, and included patients who were transplanted between 1974 and 2014 and had survived ≥2 years after BMT. Participants (aged ≥18 years) completed a survey at a median of 9 years from BMT, and were followed for a median of 5.6 years after survey completion. Survivors provided information on sociodemographic factors, chronic health conditions, health behaviors, and SRH (a single-item measure rated as excellent, very good, good, fair, or poor; excellent, very good, and good SRH were classified as good SRH, and fair and poor were classified as suboptimal SRH). The National Death Index Plus and Accurint databases and medical records provided vital status through December 2021.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of 3739 participants, 784 died after survey completion (21%). Overall, 879 BMT survivors (23.5%) reported suboptimal SRH. Pain, low socioeconomic status, psychological distress, lack of exercise, severe/life-threatening chronic health conditions, post-BMT relapse, obesity, smoking, and male sex were associated with suboptimal SRH. BMT survivors who reported suboptimal SRH had a 1.9-fold increased risk of all-cause mortality (95% confidence interval [CI], 1.6–2.3), 1.8-fold increased risk of recurrence-related mortality (95% CI, 1.4–2.5), and 1.9-fold increased risk of non–recurrence-related mortality (95% CI, 1.4–2.4) compared to those who reported good SRH.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>This single-item measure could help identify vulnerable subpopulations who could benefit from interventions to mitigate the risk for subsequent mortality.</p>\\n </section>\\n </div>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"131 1\",\"pages\":\"\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35598\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35598","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:研究人员调查了血液或骨髓移植(BMT)后次优自我评定健康状况(SRH)的发生率及其与后续全因和特定原因死亡率的关系:研究人员调查了血液或骨髓移植(BMT)后次优自我健康评价(SRH)的发生率及其与后续全因和特定病因死亡率的关系:研究参与者来自多中心血液或骨髓移植幸存者研究,包括在1974年至2014年间接受移植并在移植后存活≥2年的患者。参与者(年龄≥18 岁)在完成 BMT 后的中位数 9 年时完成了一项调查,并在完成调查后接受了中位数 5.6 年的随访。幸存者提供了有关社会人口因素、慢性健康状况、健康行为和性健康和生殖健康的信息(单项测量,分为优、很好、好、一般或差;优、很好和好的性健康和生殖健康被归类为良好的性健康和生殖健康,一般和差的性健康和生殖健康被归类为不理想的性健康和生殖健康)。国家死亡指数 Plus 和 Accurint 数据库以及医疗记录提供了截至 2021 年 12 月的生命状态:在 3739 名参与者中,有 784 人在调查结束后死亡(21%)。总体而言,879 名 BMT 幸存者(23.5%)报告了不理想的性健康和生殖健康状况。疼痛、社会经济地位低下、心理困扰、缺乏锻炼、严重/危及生命的慢性疾病、BMT 后复发、肥胖、吸烟和男性性别与亚健康状态相关。与报告SRH良好的幸存者相比,报告SRH不达标的BMT幸存者全因死亡风险增加1.9倍(95%置信区间[CI],1.6-2.3),复发相关死亡风险增加1.8倍(95%置信区间,1.4-2.5),非复发相关死亡风险增加1.9倍(95%置信区间,1.4-2.4):结论:这一单一项目的测量方法有助于识别易受干预措施影响的亚人群,以降低其后续死亡风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Self-rated health is an independent predictor of subsequent late mortality after blood or marrow transplantation: A Blood or Marrow Transplant Survivor Study report

Background

The prevalence of suboptimal self-rated health (SRH) and its association with subsequent all-cause and cause-specific mortality after blood or marrow transplantation (BMT) were examined.

Methods

Study participants were drawn from the multicenter Blood or Marrow Transplant Survivor Study, and included patients who were transplanted between 1974 and 2014 and had survived ≥2 years after BMT. Participants (aged ≥18 years) completed a survey at a median of 9 years from BMT, and were followed for a median of 5.6 years after survey completion. Survivors provided information on sociodemographic factors, chronic health conditions, health behaviors, and SRH (a single-item measure rated as excellent, very good, good, fair, or poor; excellent, very good, and good SRH were classified as good SRH, and fair and poor were classified as suboptimal SRH). The National Death Index Plus and Accurint databases and medical records provided vital status through December 2021.

Results

Of 3739 participants, 784 died after survey completion (21%). Overall, 879 BMT survivors (23.5%) reported suboptimal SRH. Pain, low socioeconomic status, psychological distress, lack of exercise, severe/life-threatening chronic health conditions, post-BMT relapse, obesity, smoking, and male sex were associated with suboptimal SRH. BMT survivors who reported suboptimal SRH had a 1.9-fold increased risk of all-cause mortality (95% confidence interval [CI], 1.6–2.3), 1.8-fold increased risk of recurrence-related mortality (95% CI, 1.4–2.5), and 1.9-fold increased risk of non–recurrence-related mortality (95% CI, 1.4–2.4) compared to those who reported good SRH.

Conclusions

This single-item measure could help identify vulnerable subpopulations who could benefit from interventions to mitigate the risk for subsequent mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信